We had the pleasure of speaking with Larry Corey (Fred Hutchinson Cancer Research Center, Seattle, WA, USA) to discuss the current status of SARS-CoV2 vaccine candidates.
His talk entitled: ‘Update on SARS-CoV2 vaccine candidates: What do the data show?’ was presented at the IAS COVID-19 Conference: Prevention 2021, 02 February 2021.
- What are the most useful target antigens for SARS-CoV2 vaccine? (0:06)
- What have we learned from the development of the currently approved vaccines, and which candidates seem most promising? (0:55)
- What is the current status of the clinical development of these candidates? (1:32)
Disclosures: Larry Corey has nothing to disclose in relation to this video.
Support: Interview and filming supported by Touch Medical Media.
Filmed as a highlight of IAS COVID-19 Conference: Prevention (Virtual) 2021.
Share this Video
Related Videos In COVID-19
Hiam Chemaitelly, ICEID 2022: COVID-19 vaccine effectiveness against SARS-CoV-2 variants
The COVID-19 pandemic remains an international public health emergency, and the emergence of new SARS-CoV-2 variants highlights concerns regarding COVID-19 breakthrough infections. Understanding emerging SARS-CoV-2 variants is especially important as the medical and public health community seeks to contain COVID-19. In this interview, Dr Hiam Chemaitelly (Weill Cornell Medicine-Qatar, Ar-Rayyan, Qatar) talked to us about […]
Leila Atmowihardjo, ERS 2022: Imatinib for Acute Respiratory Distress Syndrome Induced by COVID-19
INVENT COVID was a phase II study, which investigated the efficacy and safety of intravenous imatinib in acute respiratory distress syndrome induced by COVID-19 (Clinical Trials Identifier: NCT04794088). touchRESPIRATORY were delighted to speak with Dr. Leila Atmowihardjo (Amsterdam Medical Centers: Academic Medical Center, Amsterdam, The Netherlands) to discuss the aims, design, eligibility criteria and findings […]
Adrian Martineau, ERS 2022: Antibody Responses to SARS-CoV-2 Vaccines – the COVIDENCE UK Study
This analysis of COVIDENCE UK investigated potential sociodemographic, behavioural, clinical, pharmacological and nutritional determinants of antibody responses to administration of SARS-CoV-2 vaccination and booster doses. It was a pleasure to talk with Professor Adrian Martineau (Queen Mary University of London, London, UK) around the aims, methodology and patient population of the COVIDENCE UK study and […]
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!